In 2023, the life sciences industry was rocked by generative artificial intelligence (GenAI), which showed the potential to revolutionise everything from genetic understanding and drug research to ...
Christopher Groux is an editor, writer and accessibility advocate. Before joining the Forbes Health team, he covered Accessibility at Reviewed and gaming at Inverse and Newsweek. When he’s not ...